Protocol Design White Papers & Case Studies
-
Reducing Inventory Errors In Clinical Trials
5/8/2026
Can a digital double-check save your trial from data errors? How does verifying shipments at receipt slash inventory mistakes? Learn to protect protocol integrity and patient safety.
-
Accelerating Enrollment And Upholding Quality In Complex Oncology Trials
5/5/2026
Real-world oncology trials reveal how fast physician engagement, hands-on biomarker management, and adaptive enrollment shorten timelines, reach first-patient milestones, and preserve data quality.
-
TrialKit AI Timeline Value
4/29/2026
Automate protocol design, database builds, and validation to cut study setup from months to days — enabling faster analytics, earlier insights, and trial simulation.
-
First-In-Human To Proof-Of-Concept: The DVCR Continuity Model
4/28/2026
With a single, consistent team from FIH to Proof-of-Concept, this Continuity Model eliminates fragmented handoffs to keep program knowledge intact and speed your path to Phase II.
-
Why RWD Strategy Can't Wait With Price, Value And Evidence Pressures Everywhere
4/27/2026
Overcome pricing pressures and reimbursement delays by integrating real-world evidence early in development to align clinical outcomes with payer demands and accelerate patient access.
-
Why Life Science Organizations Need A Chief Patient Officer Function
4/27/2026
Bridging the gap between innovation and impact, this exploration of the Chief Patient Officer role offers a strategic framework to integrate patient insights and de-risk the product lifecycle.
-
Pharma R&D Annual Review Supplement: New Active Substances
4/15/2026
Last year was by some distance the best year ever in terms of new active substances. Its total of 105 new debuts easily outstrips that of the previous record holder 2021’s 97. In 2025 we saw 97 new drugs, compared to the previous record of 84.
-
Develop Site-Centric Protocols To Optimize Enrollment
4/10/2026
Optimize clinical trial protocols by aligning scientific goals with real-world site operations. Improve enrollment, reduce site burden, and minimize costly amendments through data-driven design.
-
From Months To Hours: MMC Medical's EDC Revolution
3/31/2026
Learn how a specialized CRO reduced study build times by 95%. Discover strategies for template reusability and flexible resource scaling to accelerate early-stage medical device validation.
-
Combination Therapy Dose Optimization In Oncology Trials
3/30/2026
Optimize dose selection in oncology trials by moving beyond toxicity limits. Use advanced modeling and benefit-risk analysis to improve efficacy and meet modern regulatory standards.